Name: Aquestive Therapeutics, Inc. (AQST) Balance Sheet
Creator: FinSpry

Aquestive Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aquestive Therapeutics, Inc. (AQST) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	71.55	23.87	27.27	28.02	31.81	49.33	60.60
Cash & Short-Term Investments	71.55	23.87	27.27	28.02	31.81	49.33	60.60
Accounts Receivable	4.92	8.47	4.70	12.12	6.96	13.13	6.48
Inventory	6.04	6.77	5.78	4.04	2.46	2.86	5.44
Other Current Assets	3.29	1.85	2.13	3.08	3.40	0.00	0.00
Total Current Assets	88.22	40.97	39.89	47.26	44.63	68.31	74.20
Non-Current Assets
Property, Plant & Equipment (Net)	8.98	9.74	9.30	7.78	10.32	9.73	12.21
Long-Term Investments	3.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	1.28	1.44	0.05	0.10	0.00	0.00
Other Non-Current Assets	1.22	5.44	6.45	6.90	7.84	0.29	0.24
Total Non-Current Assets	13.20	16.45	17.18	14.73	18.26	10.17	12.65
Total Assets	101.42	57.42	57.07	61.99	62.88	78.48	86.85
Current Liabilities
Accounts Payable	10.29	8.93	9.95	8.31	15.66	17.75	24.03
Short-Term Debt	0.03	0.02	18.70	2.03	2.58	0.00	0.00
Current Portion of Long-Term Debt	0.03	0.02	18.70	2.03	2.58	0.00	0.00
Accrued Liabilities	0.81	6.50	7.97	8.74	8.57	0.00	0.00
Deferred Revenue	1.05	2.47	2.66	1.99	2.14	0.00	0.00
Other Current Liabilities	1.09	4.20	1.15	1.23	6.33	1.36	0.00
Total Current Liabilities	18.87	18.31	39.53	21.96	19.65	18.56	32.95
Non-Current Liabilities
Long-Term Debt	32.50	27.34	33.45	51.55	37.18	60.34	42.60
Other Non-Current Liabilities	22.52	16.78	2.03	2.49	3.40	1.36	0.00
Total Non-Current Liabilities	142.72	82.95	136.10	122.16	91.73	66.05	43.82
Total Liabilities	161.58	163.91	175.62	144.13	111.38	84.60	76.77
Stockholders' Equity
Common Stock	0.09	0.07	0.06	0.04	0.04	0.00	0.00
Retained Earnings	-363.21	-319.08	-311.21	-256.80	-186.26	-130.47	-61.38
Additional Paid-in Capital	302.97	212.52	192.60	174.62	137.73	124.32	71.43
Shares Outstanding	91.41	68.53	54.83	41.23	0.00	0.00	0.00
Total Stockholders' Equity	-60.16	-106.49	-118.55	-82.13	-48.50	-6.12	10.08
Total Liabilities & Equity	101.42	57.42	57.07	61.99	62.88	78.48	86.85